Authors:
MENACHE D
ARONSON DL
KENNEDY D
MONTGOMERY RR
Citation: D. Menache et al., PHARMACOKINETICS OF VON-WILLEBRAND-FACTOR (HUMAN) IN PATIENTS WITH VON-WILLEBRAND-DISEASE (VWD), Thrombosis and haemostasis, 1997, pp. 2097-2097
Citation: D. Menache et Dl. Aronson, NEW TREATMENTS OF VON-WILLEBRAND-DISEASE - PLASMA-DERIVED VON-WILLEBRAND-FACTOR CONCENTRATES, Thrombosis and haemostasis, 78(1), 1997, pp. 566-570
Citation: D. Menache et Jp. Omalley, CREUTZFELDT-JAKOB-DISEASE - CURRENT US POLICY TO FURTHER REDUCE THE POSSIBLE RISK OF TRANSMISSION BY TRANSFUSION, Biologicals, 24(3), 1996, pp. 277-283
Authors:
MENACHE D
ARONSON DL
DARR F
MONTGOMERY RR
GILL JC
KRESSLER CM
LUSHER JM
PHATAK PD
SHAPIRO AD
THOMPSON AR
WHITE GC
Citation: D. Menache et al., PHARMACOKINETICS OF VON-WILLEBRAND-FACTOR AND FACTOR-VIIIC IN PATIENTS WITH SEVERE VON-WILLEBRAND DISEASE (TYPE-3 VWD) - ESTIMATION OF THE RATE OF FACTOR-VIIIC SYNTHESIS, British Journal of Haematology, 94(4), 1996, pp. 740-745
Citation: D. Menache et Jp. Omalley, SAFETY MONITORING AND EPIDEMIOLOGIC SURVEILLANCE OF BLOOD-TRANSFUSIONIN THE UNITED-STATES, Transfusion clinique et biologique, 2(1), 1995, pp. 7-12
Authors:
MENACHE D
ARONSON DL
DARR F
MONTGOMERY RR
Citation: D. Menache et al., RATE OF SYNTHESIS OF FACTOR-VIII AND DECAY OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR (VWF) IN SEVERE VON-WILLEBRAND DISEASE (VWD), Blood, 84(10), 1994, pp. 10000238-10000238